PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Acteoside Improves Muscle Atrophy and Motor Function by Inducing New Myokine Secretion in Chronic Spinal Cord Injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30318996 ↗2019Reported benefit

Acteoside Improves Muscle Atrophy and Motor Function by Inducing New Myokine Secretion in Chronic Spinal Cord Injury.

MouseSpinal cord injuryContusionddYFemalen = Acteoside n = 8 mice, vehicle n = 8 mice, sham n = 6 mice;…Intramuscular0.1 mg per limb, injected into the right and left hindlimbsTreatment started 30 days after spinal cord injury

Model: Contusive spinal cord injury; laminectomy at T11 with a 13.5 g rod of 1 mm tip diameter dropped from 3 cm onto the exposed L1 segment, approximately 13.5 kdyn, treated in the chronic phase

Intramuscular acteoside in chronic spinal cord injured mice significantly improved Basso Mouse Scale and Toyama Mouse Score, increased gastrocnemius and tibialis anterior weights and increased caudal 5-HT axonal and presynaptic density relative to vehicle.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.